A Breast Cancer Treatment Shows Clinical Activity in Multiple Cancer Types
A new study suggests that a HER2-targeted therapy approved for breast cancer may be effective for several other cancers....
A new study suggests that a HER2-targeted therapy approved for breast cancer may be effective for several other cancers....
A targeted therapy regimen was approved to treat some children with brain cancer The U.S. Food and Drug Administration...
Clinical trial results suggest patients with high-risk chronic lymphocytic leukemia may benefit from a combination of two targeted therapeutics....
A drug that selectively targets cancer cells was approved for the treatment of certain HR-positive breast cancers. The U.S....
The immune checkpoint inhibitor durvalumab was approved in combination with chemotherapy for certain biliary tract cancers that have spread. ...
Mirvetuximab soravtansine-gynx was approved for certain ovarian, fallopian tube, and peritoneal cancers. The U.S. Food and Drug Administration (FDA)...
Researchers recently developed a risk prediction model that could categorize individuals with lung nodules as having high or low...
The FDA has approved a new molecularly targeted therapeutic for treating certain patients who have advanced gastrointestinal stromal tumors. The...
The FDA approved the combination of an immune checkpoint inhibitor and a therapeutic that prevents tumors from growing blood...
The FDA has approved a new targeted therapeutic for certain patients with HER2-positive breast cancer who were previously treated with other targeted therapies....
The U.S. FDA approved a monoclonal antibody and enzyme combination for use in conjunction with chemotherapy and a steroid...
The U.S. FDA approved a combination of a molecularly targeted therapeutic and an immunotherapeutic to treat certain patients with...
The FDA has approved osimertinib plus chemotherapy for non-small cell lung cancer with EGFR mutations. The U.S. Food and...
The FDA has approved pembrolizumab for the first-line treatment of certain HER2-negative gastric and gastroesophageal junction cancers. The U.S....
The FDA has approved amivantamab-vmjw, both alone and in combination with chemotherapy, for the treatment of certain non-small cell...
Identifying people at the highest risk for pancreatic cancer could better identify those who should be screened to catch...
Approved immunotherapeutics release different brakes on the immune system. A new combination of cancer immunotherapeutics – ipilimumab (Yervoy) and...
The FDA approved the use of an immune checkpoint inhibitor as a first-line treatment for patients with colorectal cancers...
The FDA has approved a new molecularly targeted therapeutic for treating certain patients with advanced or metastatic HER2-positive breast...
The FDA has approved a combination of the immune checkpoint inhibitor atezolizumab with two targeted therapies for certain patients...
The FDA approved the molecularly targeted therapeutic tivozanib to treat certain adult patients with the most common type of...
The U.S. Food and Drug Administration approval provides a new option for patients whose disease is driven by mutations...
The FDA has approved nirogacestat for the treatment of noncancerous but painful growths called desmoid tumors. The U.S. Food...
the immunotherapeutic pembrolizumab in combination with chemotherapy WAS APPROVED to treat certain adult patients with esophageal cancer. The U.S....
The U.S. FDA approved a molecularly targeted therapeutic to treat certain patients with cholangiocarcinoma. The U.S. Food and Drug...
Single test could identify one prognostic and seven predictive biomarkers in blood PHILADELPHIA – Guardant360, a liquid biopsy test...
Fewer than half of patients with unsatisfactory samples from fecal immunochemical tests completed follow-up testing within 15 months PHILADELPHIA...
PHILADELPHIA – Incorporation of pan-cancer microsatellite instability (MSI) detection into the 74-gene panel Guardant360 liquid biopsy assay showed high...
HPV testing eight years after a negative result instead of the recommended five was found comparable to standard cytology...
Test employs error correction to increase accuracy PHILADELPHIA – A new liquid biopsy test could detect microsatellite instability (MSI)...